SNG001 Anti-Viral
We have discovered and developed a new anti-viral drug (SNG001) that could potentially help reduce the number of hospital admissions for…
Richard Marsden
Richard Marsden is the CEO of Synairgen plc, a respiratory drug development company founded by the University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic